Saturday, July 11, 2026

pharma · Renal Impairment · Osteoarthritis, Knee / Osteoarthritis, Hip

Tanabe Pharma

Tanabe Pharma clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Osaka, JP HQ
1678 Founded
104 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Osaka, JP
Founded
1678
Employees
104
Programs
4
Drugs
1
Patents
0
Intelligence · Clinical Programs

Tanabe Pharma projects

2 ClinicalTrials.gov programs sponsored by Tanabe Pharma.

Tanabe Pharma has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. MCI-186

    Tanabe Pharma

    Renal Impairment

    phase 1 small molecule completed

    1 trial
  2. MT-1186

    Tanabe Pharma

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Tanabe Pharma have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.